Protagenic Therapeutics, Inc.new
No enriched coverage for $PTIX in the last 7 days.
No SEC Form 4 filings for $PTIX in the last 30 days.
Shares of Protagenic Therapeutics are trading sharply higher Thursday afternoon. The stock soared over 100% midday after the company announced a key clinical milestone. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here →
NEW YORK, May 27, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Inozyme Pharma, Inc.
BALA CYNWYD, Pa., May 27, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
